3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
37
Neoplasm Metastasis
6
Neoplasms by Site
2
Neoplasms
2
Hereditary Sensory and Autonomic Neuropathies
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Diseases
2
Anatomic Stage II Breast Cancer AJCC v8
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Sarcoma
1
Recurrence
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Melanoma
1
Lung Neoplasms
1
Locoregional Recurrence
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
Liposarcoma
1
Leiomyosarcoma
1
Head and Neck Neoplasms
1
HR+/HER2- Breast Cancer
1
HER2 Negative Breast Cancer Not Immediately Operated
1
HER2 Negative Breast Cancer
1
Glioma
1
Glioblastoma
1
Interventions
Specimen Handling
7
Magnetic Resonance Spectroscopy
5
Biopsy
5
Nivolumab
3
pembrolizumab
2
X-Rays
2
trastuzumab deruxtecan
1
pelcitoclax
1
olaparib
1
durvalumab
1
cobimetinib
1
ceralasertib
1
cediranib
1
capivasertib
1
cabozantinib
1
Taxes
1
Radiation
1
Phantoms, Imaging
1
Paclitaxel
1
Minimally Invasive Surgical Procedures
1
Ipilimumab
1
Indocyanine Green
1
Immunoglobulin G
1
Fluid Therapy
1
Disulfides
1
Congresses as Topic
1
Carboplatin
1
CTLA-4 Antigen
1
Brachytherapy
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinosarcoma
×
ribociclib
×
90 days
×
Clear all
No trials found.